DRUG

Semaglutide

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for Semaglutide

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
GLP-1R pancreatic ductal adenocarcinoma 0.248 Mid partial evidence none

Clinical trials

200 registered trials for Semaglutide

Source: ClinicalTrials.gov

← All drugs